Yildiz, J. Et Al. 2022. The clinicopathological features and survival of Castleman disease: A multicenter Turkish study. European Review for Medical and Pharmacological Sciences , vol.26, no.4 , 1131-1137.

Yildiz, J., Bagci, M., Sayin, S., Kaya, A., Yilmaz, F., Ekinci, O., ... Dal, M.(2022). The clinicopathological features and survival of Castleman disease: A multicenter Turkish study. European Review for Medical and Pharmacological Sciences , vol.26, no.4, 1131-1137.

Yildiz, Jale Et Al. "The clinicopathological features and survival of Castleman disease: A multicenter Turkish study," European Review for Medical and Pharmacological Sciences , vol.26, no.4, 1131-1137, 2022

Yildiz, Jale Et Al. "The clinicopathological features and survival of Castleman disease: A multicenter Turkish study." European Review for Medical and Pharmacological Sciences , vol.26, no.4, pp.1131-1137, 2022

Yildiz, J. Et Al. (2022) . "The clinicopathological features and survival of Castleman disease: A multicenter Turkish study." European Review for Medical and Pharmacological Sciences , vol.26, no.4, pp.1131-1137.

@article{article, author={Jale Yildiz Et Al. }, title={The clinicopathological features and survival of Castleman disease: A multicenter Turkish study}, journal={European Review for Medical and Pharmacological Sciences}, year=2022, pages={1131-1137} }